Parse Biosciences, a QIAGEN Company, Launches FFPE-compatible Barcoding Technology for Whole Transcriptome Single Cell Analysis

Parse Biosciences, a QIAGEN company and the leading provider of scalable and accessible single-cell sequencing solutions, today announced the commercial availability of Evercode (TM) Whole ...
Lodi News-Sentinel

10x Genomics Introduces Atera, a New Platform to Redefine How Biology is Measured and Understood

PLEASANTON, Calif., April 18, 2026 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial ...
Zacks Investment Research on MSN

10x Genomics stock up on Atera launch, spatial biology scale enhanced

10x Genomics TXG recently unveiled Atera, a next-generation in situ spatial biology platform designed to deliver ...
PharmiWeb

Takara Bio USA, Inc. Launches Certified Service Provider Program to Advance Research Using NGS and Single-Cell Technologies

New program matches top researchers with expert service providers trained to offer a comprehensive suite of Shasta® ...
Morningstar

Parse Biosciences Launches Evercode Whole Transcriptome V4 With Shorter Workflow, Higher Sensitivity and Higher Cell Recovery

New chemistry reduces barriers to scaling single-cell studies across research settings Launch planned for March 2026, available across Evercode Whole Transcriptome product line Parse Biosciences, a ...
Pharmaceutical Technology on MSNOpinion

Advancing single-cell transcriptomics into the mainstream of biomedical research

Kelly Parliament, staff application scientist at Beckman Coulter Life Sciences, discusses how automation is improving the ...
News Medical

Comprehensive RNA analysis in single cells with short-read sequencing

This article and associated images are based on a poster originally authored by Marisa Amato and presented at ELRIG Drug Discovery 2025 in affiliation with Singleron Biotechnologies GmbH. This poster ...